Phase 1 biotech developing G-protein-coupled receptors for chronic diseases.
Industry: Health Care
Latest Trade: $39.22 -0.52 (-1.3%)
First Day Return: +73.3%
Return from IPO: +164.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/12/2023 |
Offer Price | $15.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 10.7 |
Deal Size ($mm) | $161 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/02/2023 |
Offer Price | $15.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 10.7 |
Deal Size ($mm) | $161 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Jefferies |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2016 |
Employees at IPO | 68 |
Website www.structuretx.com |